Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo

BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer related deaths in America. Monoclonal antibodies are a viable treatment option for inhibiting cancer growth. Tumor specific drug delivery could be achieved utilizing these monoclonal antibodies as targeting agents. This type of desi...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Khan, Jameel Ahmad, Kudgus, Rachel A., Szabolcs, Annamaria, Dutta, Shamit, Wang, Enfeng, Cao, Sheng, Curran, Geoffry L., Shah, Vijay, Curley, Steven, Mukhopadhyay, Debabrata, Robertson, J. David, Bhattacharya, Resham, Mukherjee, Priyabrata
Format: Artigo
Język:Inglês
Wydane: Public Library of Science 2011
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3124468/
https://ncbi.nlm.nih.gov/pubmed/21738572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0020347
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy